XML 79 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Feb. 28, 2019
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Goodwill   $ 140,627,000 $ 140,627,000  
Estimated fair value of contingent consideration, short term liabilities     55,345,000  
Estimated fair value of contingent consideration, long-term liabilities   109,606,000 95,034,000  
Change in the estimated fair value of contingent consideration   (40,773,000) (3,364,000) $ 31,842,000
Cobalt Biomedicine, Inc | Acquisition Agreement        
Business Acquisition [Line Items]        
Business acquisition, percentage of voting interests acquired 100.00%      
Business acquisition, impairment of intangible assets or goodwill $ 0      
Goodwill 140,600,000 140,600,000    
Maximum contingent consideration upon achievement of certain pre-specified development milestones $ 500,000,000      
Maximum term for success payment 20 years      
Cobalt Biomedicine, Inc | Acquisition Agreement | Research and Development Expense        
Business Acquisition [Line Items]        
Estimated fair value of contingent consideration   109,600,000 150,400,000  
Estimated fair value of contingent consideration, short term liabilities     55,400,000  
Estimated fair value of contingent consideration, long-term liabilities     95,000,000  
Change in estimated fair value of success payment   (7,900,000) (69,300,000) 23,600,000
Change in the estimated fair value of contingent consideration   (40,800,000) (3,400,000) $ 31,800,000
Cobalt Biomedicine, Inc | Acquisition Agreement | Long-term Liabilities | Research and Development Expense        
Business Acquisition [Line Items]        
Estimated fair value of success payment liability   $ 11,200,000 $ 19,000,000  
Cobalt Biomedicine, Inc | Acquisition Agreement | Minimum        
Business Acquisition [Line Items]        
Threshold market capitalization $ 8,100,000,000      
Cobalt Biomedicine, Inc | Acquisition Agreement | Market Capitalization Equal to or Exceeds $8.1 billion        
Business Acquisition [Line Items]        
Cobalt success payment 500,000,000      
Cobalt Biomedicine, Inc | Acquisition Agreement | IPR&D        
Business Acquisition [Line Items]        
Business combination, intangible assets $ 59,200,000